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cytokine production and impairs 
repair and corticosteroid 
responsiveness in lung epithelium
R. F. Hoffmann1,2, M. R. Jonker1,2, S. M. Brandenburg1, H. G. de Bruin1,2, N. H. T. ten Hacken2,3, 
A. J. M. van Oosterhout1,2 & i. H. Heijink1,2,3*
COPD is characterized by chronic lung inflammation and irreversible lung tissue damage. Inhaled 
noxious gases, including cigarette smoke, are the major risk factor for COPD. Inhaled smoke first 
encounters the epithelial lining of the lungs, causing oxidative stress and mitochondrial dysfunction. 
We investigated whether a mitochondrial defect may contribute to increased lung epithelial pro-
inflammatory responses, impaired epithelial repair and reduced corticosteroid sensitivity as observed 
in COPD. We used wild-type alveolar epithelial cells A549 and mitochondrial DNA-depleted A549 cells 
(A549 Rho-0) and studied pro-inflammatory responses using (multiplex) ELISA as well as epithelial 
barrier function and repair (real-time impedance measurements), in the presence and absence of 
the inhaled corticosteroid budesonide. We observed that A549 Rho-0 cells secrete higher levels of 
pro-inflammatory cytokines than wild-type A549 cells and display impaired repair upon wounding. 
Budesonide strongly suppressed the production of neutrophil attractant CXCL8, and promoted 
epithelial integrity in A549 wild-type cells, while A549 Rho-0 cells displayed reduced corticosteroid 
sensitivity compared to wild-type cells. The reduced corticosteroid responsiveness may be mediated 
by glycolytic reprogramming, specifically glycolysis-associated PI3K signaling, as PI3K inhibitor 
LY294002 restored the sensitivity of CXCL8 secretion to corticosteroids in A549 Rho-0 cells. In 
conclusion, mitochondrial defects may lead to increased lung epithelial pro-inflammatory responses, 
reduced epithelial repair and reduced corticosteroid responsiveness in lung epithelium, thus potentially 
contributing to the pathogenesis of COPD.
Chronic obstructive pulmonary disease (COPD) is a complex disease with increasing morbidity and mortality 
worldwide, characterized by irreversible airflow limitation and accelerated lung function decline. COPD is mainly 
caused by noxious environmental factors, including cigarette smoke, resulting in exaggerated lung inflamma-
tory responses. Abnormal tissue repair upon cigarette smoke-induced inflammation and damage is an important 
pathophysiologic feature of COPD, leading to fibrosis in the small airways and/or destruction of lung tissue 
(emphysema). Despite their broad anti-inflammatory effects, inhaled corticosteroids (ICS) provide relatively little 
therapeutic benefit in COPD. They reduce exacerbations, but do not effectively change the course of the disease 
nor the tissue damage that results from chronic airway inflammation1–5. Furthermore, we recently observed that 
airway epithelial cells from COPD patients display reduced responsiveness to corticosteroids2.
Inhaled cigarette smoke first encounters the epithelial lining of the lungs, where it induces oxidative stress. 
This inflicts mitochondrial dysfunction and cellular damage in lung epithelium, promoting the release of 
cytokines that attract and activate neutrophils, e.g. CXCL86. In addition, oxidative stress has been implicated in 
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corticosteroid unresponsiveness1,7. Mitochondria are major intracellular targets of oxidative stress. Our previous 
findings indicate that bronchial epithelial cells from COPD patients display mitochondrial abnormalities, with 
depletion of cristae, increased expression of mitochondrial stress marker PINK1 and persistent mitochondrial 
damage. Similar mitochondrial changes were observed in epithelial cells that were exposed to cigarette smoke 
in vitro for 6 months, which was accompanied by increased pro-inflammatory activity8. In addition, increased 
PINK1 expression has been observed in alveolar epithelium of COPD patients9. However, it is currently unknown 
whether mitochondrial dysfunction contributes to aberrant epithelial pro-inflammatory activity and damage and 
repair responses in COPD. Of interest, Islam et al. have shown that transfer of intact mitochondria by mesen-
chymal stem/stromal cells can contribute to lung tissue repair in a mouse model of lethal lung injury, suggesting 
that intact mitochondria may play be crucial for lung regeneration and that loss of mitochondrial function may 
impair this process10. Furthermore, loss of mitochondrial function is known to lead to metabolic reprogramming 
with a switch to glycolysis, which has been implicated in corticosteroid resistance in lymphoblastic leukemia11,12. 
The causal role of metabolic reprogramming in the pathogenesis of COPD is not well known. Therefore, our aim 
was to investigate whether mitochondrial dysfunction is sufficient to induce epithelial abnormalities as observed 
in COPD.
We hypothesized that mitochondrial dysfunction has important implications for lung epithelial responses, 
leading to increased pro-inflammatory activity, altered ICS responsiveness and impaired epithelial repair 
responses. To address our hypothesis, we compared wild-type human alveolar A549 cells and A549 cells 
with depleted of functional mitochondria, A549 Rho-0. We show that A549 Rho-0 produce higher levels of 
pro-inflammatory cytokines, are less responsive to corticosteroids and display impaired repair responses com-
pared to wild-type A549 cells.
Material and Methods
cell culture. The wild type alveolar carcinoma cell line A549 and mitochondria-depleted A549 Rho-0 cells 
were kindly provided by Dr. Lodovica Vergani (Padova University, Padova, Italy), created and characterized as 
described previously13,14 by culturing A549 in addition of 50 ng/mL Ethidium Bromide for 8–12 passages. Cells 
were cultured in Dulbecco’s Modified Eagle’s medium (DMEM, Sigma, St. Louis, MO, (D6429-500ML) supple-
mented with MEM Amino Acids (50×) solution (Sigma, M7020-100ML), MEM Non-essential Amino Acid 
Solution, (Sigma, M7145-100ML), vitamins (Sigma, M6895-100ML) sodium pyruvate, uridine 50 ng/ml (Sigma, 
cat. n. U-3003), 2,5 µg/ml amphotericin (Sigma-A2942-100ML), 25% foetal bovine serum (FBS; Hyclone, Logan, 
UT), 100 U/ml penicillin and 100 µg/ml streptomycin (Invitrogen (Gibco), Breda, The Netherlands) in uncoated 
T25 flasks. Before experimentation, cells were grown ∼90% confluence and serum-deprived overnight.
pcR. RNA was isolated from cells or lung tissue using TRIzol. Samples were treated with RNAse Free DNAse 
and subsequently cleaned with RNeasy Mini Kit (Qiagen, Valencia, CA). cDNA was synthesized with the iScript 
cDNA Synthesis Kit (BioRad, Hercules, CA). Gene expression was analyzed by real-time PCR using the Taqman® 
according to the manufacturer’s guidelines (Applied Biosystems, Foster City, CA). the TaqMan Master Mix and 
validated probes for NADH dehydrogenase (complex I), cytochrome C oxidase (complex IV) subunit III and ATPase 
subunit F1α (complex V), and the housekeeping genes β2-microglobulin (β2µG) and Peptidylprolyl isomerase A 
(PPIA) were purchased from Applied Biosystems. Relative mRNA expression was normalized to the mean expres-
sion of the housekeeping genes (2−ΔCt).
Western blotting. Cell lysates were prepared and immunodetection was performed as described previ-
ously15 using MitoProfile total OXPHOS antibody cocktail (Mitosciences, Eugene OR) anti-Mn-SOD (EMD 
Millipore Corporation, Billerica MA) and anti-GAPDH (Cell Signalling Technology, Danvers MA, USA) as load-
ing control. Densitometry was performed using the gel-scan program QuantityOne.
Atp assay. Intracellular ATP levels of A549 were measured after ATP extraction. To extract ATP, cells were 
lysed using 0.5% TCA. Subsequently, TCA was neutralized with TE-buffer. ATP was measured with the lucif-
erin–luciferase method (Enliten ATP assay system, Promega). Briefly, 100 μl sample was added to 50 μl of ATP 
assay mix and the luminescence was measured with a Luminoskan® Ascent microplate luminometer (Thermo 
Scientific, Waltham, USA) for 1 hour.
Lactate assay. Lactate levels were measured in cell-free culture supernatants (24 hours) using a lactate assay 
kit (BioVision, Milpitas, USA) according to manufacturer’s protocol.
cytokine levels. Cell-free culture supernatants (24 hours) were collected and analysed for CXCL8 using a 
duo-set ELISA assay (R&D Systems Europe, Abingdon, UK) or analysed for CCL20, CXCL10 (IP-10), CCL2 
(MCP-1), CCL3 (MIP-1α), CCL4 (MIP-1β), CCL5 (RANTES), G-CSF, IL-6 and IL-12 using a multiplex ELISA 
(Millipore, Billerica, MD) following manufacturer’s instructions.
eciS. Electrical resistance properties of confluent or wounded cells were measured using Electric 
Cell-substrate Impedance Sensing (ECIS, Applied Biophysics, Troy, NY, USA) as described previously16. Upon 
inoculation in ECIS arrays, cells were incubated with/without 10 nM budesonide for 48 hours and resistance 
and capacitance were measured at 400 Hz and 40 kHz respectively. Cells were wounded by electroporation (5 V, 
40 kHz, 30 s) upon establishment of a confluent monolayer.
Confocal microscopy. Cells were stained with JC1, MitoTracker® DeepRed FM and dsDNA stain Picogreen 
(Molecular Probes, Invitrogen) for 45 minutes in D-PBS (GIBCO, 14287-080) according to manufacture protocol. 
Subsequently, cells were washed twice with D-PBS and visualized using a Leica AOBS confocal microscope.
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Statistical analysis. Differences between the wild type and Rho-0 cells were evaluated by the Mann-Whitney 
test, 2-way ANOVA for time curves or the Wilcoxon signed rank for differences within the cell lines, as indicated 
in the figure legends. P = < 0.05 was considered statistically significant.
Figure 1. Mitochondrial (mt)DNA depletion and mitochondrial dysfunction in A549 Rho-0 cells. A549 wild-
type (wt) and Rho-0 cells were grown to confluence and serum deprived for 24 hrs. (A) Cells were stained with 
Picogreen for detection of the DNA and Mitotracker DeepRed. Co-localization of DNA and mitochondrial 
bodies indicates mtDNA. Representatives of 3 independent experiments are shown. (B) Cells were stained 
with JC1 staining mitochondrial membrane potential is lowered by depletion of mtDNA in the A549 Rho-0 
cells when compared to control cells. (C) ATP (mean ± SEM, n = 6–7) and (D) lactate (mean ± SEM, n = 3) 
were measured in cell-free culture supernatants. (E) RNA was isolated, cDNA synthesized, mRNA expression 
of NADH dehydrogenase (complex I), cytochrome c oxidase (complex IV) subunit III and ATPase subunit F1α 
(complex V) analyzed by qPCR and related to the expression of housekeeping genes β2µG and PPIA. (F) 
Cell lysates were prepared and complex III, Complex IV and the ATPase subunit components were detected 
by western blotting, analysed by densitometry and related to GAPDH (mean ± SEM, n = 3). *p < 0.05 and 
**p < 0.01 between the indicated values as measured by the one-tailed Mann-Whitney test.
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Results
Depletion of mitochondrial (mt)DNA and characterization of mitochondrial dysfunction in 
A549 Rho-0 compared to wild-type A549 cells. First, we assessed whether mtDNA was successfully 
depleted in the A549 Rho-0 cells. We analyzed both wild-type A549 and A549 Rho-0 cell lines for the presence of 
mtDNA and mitochondrial bodies. Co-localization of DNA (Picogreen) and mitochondrial bodies (Mitotracker 
DeepRed) was clearly visible in wild-type A549, but not in A549 Rho-0 cells, confirming the lack of mtDNA 
(Fig. 1A). JC1 staining showed a drastic decrease in mitochondrial membrane potential the A549 Rho-0 cells 
(Fig. 1B). Surprisingly, the intra-cellular concentrations of ATP did not differ between the wild-type A549 and 
the A549 Rho-0 cells, indicating an alternative pathway for ATP generation than the mitochondrial-mediated 
oxidative phosphorylation (OXPHOS) process in A549 Rho-0 cells (Fig. 1C). Loss of mitochondrial function may 
lead to compensatory secondary metabolism, glycolysis, to produce ATP as well as lactate. To confirm a glycolytic 
switch in the A549 Rho-0 cells, we analyzed lactate production. Indeed, lactate levels in the culture medium of 
A549 Rho-0 cells were significantly increased when compared to wild-type A549 cells (Fig. 1D). This glycolytic 
reprogramming was further supported by a significant reduction in the mRNA and/or protein expression of 
Figure 2. Increased pro-inflammatory activity in A549 Rho-0 compared to wild-type A549 cells. A549 wild-
type (wt) and Rho-0 cells were grown to confluence, serum deprived overnight and supernatants were collected 
24 hours later. (A) CXCL8 (mean ± SEM, n = 5) and (B) CCL20, CXCL10, CCL2, CCL3, CCL4, CCL5, G-CSF, 
IL-6 and IL-12 (mean ± SEM, n = 5) levels (pg/ml) were measured in cell-free supernatants using ELISA and 
multiplex ELISA respectively. *p < 0.05 and **p < 0.01 between the indicated values as analysed by the two-
tailed Mann-Whitney test.
Figure 3. A549 Rho-0 cells display reduced wound repair compared to wild-type A549 cells. (A) A549 wild-
type and Rho-0 cells were seeded in a density of 100.000 cells/well in duplicates in ECIS arrays and grown to 
confluence for 24 hours. Resistance was measured at a frequency of 400 Hz (mean ± SEM, n = 4). (B) Confluent 
monolayers were wounded by electroporation. Resistance was monitored for 8 hours at 400 Hz and levels were 
normalized to the values immediately after wounding (mean ± SEM, n = 4). **p < 0.01 between the indicated 
values as analyzed by 2-way ANOVA.
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Figure 4. A549 Rho-0 cells are less sensitive to budesonide than wild-type A549 cells, which is restored 
by blocking of PI3K/Akt signaling. (A) A549 wild-type and Rho-0 cells were grown to confluence, serum 
deprived overnight and incubated with/without budesonide (BUD, 10 nM) for 24 hours. CXCL8 was 
measured in cell-free supernatant and expressed as absolute values and as percentage of the levels without 
BUD (mean ± SEM, n = 56). (B) A549 wild-type and Rho-0 cells were grown to confluence in ECIS arrays for 
24 hours. Subsequently, 10 nM budesonide (BUD) or vehicle was added and cells were cultured for another 
48 hours. Resistance was monitored at 400 Hz and normalized to the levels immediately after the addition of 
BUD (mean ± SEM, n = 4). (C) A549 wild-type and Rho-0 cells were grown to confluence, serum deprived 
overnight and incubated with/without budesonide (BUD, 10 nM) for 24 hours. LY294002 (10 µM) was added 
30 min before the exposure to BUD. CXCL8 was measured in cell-free supernatant. CXCL8 levels (mean ± SEM, 
n = 5) are expressed as percentage of the levels without BUD. (D) A549 wild-type and Rho-0 cells were grown 
in ECIS arrays. Confluent monolayers were wounded by electroporation. LY294002 (10 µM) was added 60 min 
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specific components of the OXPHOS system, complex I, complex III subunit core 2 and complex IV subunit 2,3 
(Fig. 1E,F). The expression of nuclear-encoded ATPase subunit α was not affected, indicating that only mito-
chondrial DNA was depleted in the Rho-0 cells. As activation of the redox sensitive PI3K/Akt pathway has been 
implicated in the switch to glycolysis, we studied phosphorylation of Akt and observed higher phospho-Akt levels 
in Rho-0 compared to wild-type A549 cells, in further support of the glycolytic switch (Supplementary Fig. 1).
Elevated pro-inflammatory cytokine/chemokine secretion in A549 Rho-0 cells. Next, we stud-
ied the effect of mitochondrial dysfunction on the pro-inflammatory cytokine response of lung epithelial cells. 
We measured a panel of pro-inflammatory epithelial cytokines/chemokines that have been associated with 
lung inflammation in COPD patients and/or show increased levels in COPD lungs, i.e. CXCL817,18, CCL2019,20, 
CXCL10 (IP10)21–23, CCL224, CCL325, CCL4, CCL5 26, G-CSF27, IL-628,29 and IL-1221,30,31. Of these, the secretion 
of CXCL8 (Fig. 2A), CCL20, CCL3, CCL4, G-CSF, IL-6 and IL-12 was significantly higher in Rho-0 compared 
to wild-type A549 cells (Fig. 2B), while baseline levels of CXCL8 in wild-type A549 cells were within the same 
range as in primary airway epithelial cells2. A trend towards higher levels was observed for CCL5 and CXCL10, 
while CCL2 secretion was not different between A549 wild-type and Rho-0 cells (Fig. 2B). Collectively, these data 
suggest that mtDNA depletion results in an increased pro-inflammatory response in lung epithelial cells.
Reduced repair capacity in A549 Rho-0 cells. In addition to pro-inflammatory responses, we studied 
whether mitochondrial dysfunction impacts on the integrity of the epithelial monolayer and its recovery upon 
injury by electroporation using electric cell-surface impedance sensing (ECIS). We assessed A549 integrity by the 
build-up of resistance upon growth to confluence, which we previously demonstrated to depend more strongly on 
cell-substrate contacts than on formation of intracellular junctions in A549 cells using ECIS16. We did not observe 
a significant difference between A549 wild-type and Rho-0 cells in absolute resistance values upon establishment 
of a confluent monolayer (Fig. 3A). Next, we assessed the ability to recover the monolayer upon wounding by 
electroporation, requiring epithelial migration to repopulate the damaged area, as measured by the increase in 
resistance16. Wild-type A549 were able to recover from this type of wounding within 2–4 hours, as indicated 
by the stabilization of the resistance levels (Fig. 3B). The repair response of A549 Rho-0 cells was attenuated, 
taking approximately two times longer than wild-type A549 cells to recover, as reflected by delayed stabilization 
of resistance values (Fig. 3B). This suggests that mtDNA depletion reduces epithelial repair capacity specifically 
after injury.
A549 Rho-0 cells display reduced corticosteroid responsiveness. To investigate whether mitochon-
drial dysfunction also reduces the responsiveness to corticosteroids, as has been observed in COPD and for 
CXCL8 production in airway epithelial cells upon exposure to oxidative stress32, we studied the suppressive effect 
of the ICS budesonide on CXCL8 secretion in wild-type A549 and A549 Rho-0 cells. We observed that budes-
onide significantly suppressed CXCL8 secretion by approximately 75–80% in wild-type A549 cells. Of interest, 
budesonide failed to significantly inhibit CXCL8 secretion in A549 Rho-0 cells (Fig. 4A). This suggests that the 
pro-inflammatory response triggered by mitochondrial dysfunction triggers is insensitive to corticosteroids.
In addition to the suppressive effects on cytokines, we have previously reported that corticosteroids exert 
protective effects on epithelial barrier function2. Therefore, we tested whether mitochondrial dysfunction also 
impairs the responsiveness to ICS with respect to effects on epithelial integrity. We monitored resistance as meas-
ure of epithelial integrity in the presence and absence of budesonide16. The presence of budesonide significantly 
increased the resistance in wild-type A549 cells, while A549 Rho-0 cells were again less responsive to budesonide, 
which was not able to significantly resistance in these cells (Fig. 4B).
Next, we studied whether the observed switch to glycolysis and activation of the associated redox sensitive 
PI3K/Akt signaling pathway is involved in the observed ICS insensitivity in A549 Rho-0 cells, as PI3K has pre-
viously been implicated in corticosteroid unresponsiveness in COPD33. We blocked PI3K/Akt activity using the 
specific inhibitor LY294002 (10 μM). In both wild-type A549 and A549 Rho-0 cells, we observed a marked reduc-
tion in CXCL8 secretion when the PI3K pathway was blocked (Fig. 4C). LY294002 was not able to further reduce 
CXCL8 secretion in A549 Rho-0 cells when budesonide was present, indicating that budesonide maximally inhib-
ited CXCL8 expression. Of note, inhibition of the PI3K/Akt pathway restored the sensitivity to ICS in A549 Rho-0 
cells. In contrast to the absence of LY294002, budesonide significantly reduced CXCL8 secretion in A549 Rho-0 
cells in the presence of LY294002 (Fig. 4C). Thus, our data suggest that the mitochondrial defect in A549 Rho-0 
cells induces PI3K/Akt-mediated corticosteroid insensitivity in lung epithelial cells. Finally, we studied the effect 
of PI3K/Akt inhibition on the repair capacity of A549 Rho-0 cells. In the presence of LY294002, A549 Rho-0 cells 
were unable to recover from wounding, whereas LY294002 did not affect the ability to recover from wounding 
in wild-type A549 cells (Fig. 4D). This indicates that Rho-0 cells are dependent on PI3K activity for their repair 
response, while this is not the case for wild-type cells, further confirming the reliance on PI3K-dependent glyc-
olysis in A549 Rho-0 cells.
prior to wounding. Resistance was monitored for 8 hours at 400 Hz and levels were normalized to the values 
immediately after wounding (mean ± SEM, n = 4). *p < 0.05, **p < 0.01 ***p < 0.001 between the indicated 
values as assessed by the Wilcoxon signed rank test within cell lines, the Mann Witney test between cell lines, 
1-way ANOVA with Bonferroni’s multiple comparison test for panel c, 2-way ANOVA for ECIS data.
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Discussion
We show for the first time that human alveolar epithelial cells lacking functional mitochondria display increased 
production of pro-inflammatory cytokines and impaired repair responses. This is accompanied by reduced 
responsiveness to corticosteroids, which may be mediated by activation of the glycolysis. While ATP production 
was not impaired in A549 cells with dysfunctional mitochondria, we observed higher levels of lactate, and inhibi-
tion of the glycolysis-associated PI3K pathway restored corticosteroid sensitivity in A549 Rho-0 cells.
We previously observed that long-term cigarette smoke-exposed bronchial epithelial cells as well as bron-
chial epithelial cells from COPD patients display mitochondrial abnormalities8. These together with our current 
findings may help to explain the reduced corticosteroid responsiveness in bronchial epithelial cells from COPD 
patients compared to those from smoking and non-smoking controls2. Moreover, airway epithelial cells from 
COPD patients have been reported to secrete higher levels of CXCL8 than epithelial cells from controls34, which 
may also be related to mitochondrial dysfunction. Our previous data show that mitochondrial dysfunction is 
accompanied by increased secretion of the pro-inflammatory cytokines CXCL8 and IL-68. Here, we show that 
the depletion of functional mitochondria leads to increased levels of CXCL8 and IL-6 as well as CCL20, G-CSF, 
CCL3 and CCL4, and IL-12, all pro-inflammatory cytokines that were found to be increased in lungs of COPD 
patients17–21,24,25,27–31,35.
The effect of depletion of functional mitochondria on these pro-inflammatory cytokines/chemokines was not 
a general effect on cytokine release, as for instance the secretion of CCL2 was not affected by depletion of mtDNA. 
Therefore, activation of specific pathways and/or transcription factors is more likely involved. Our findings may 
have important implications, as CXCL8 is a well know chemoattractant for neutrophils, which produce reactive 
oxygen species (ROS) and various proteases such as neutrophil elastase to damage the mitochondria and directly 
cause alveolar tissue damage in a positive feedback loop.
When depleted of mtDNA, cells cannot perform normal electron transport for ATP synthesis and rely on 
ATP derived from glycolysis, where glucose is metabolized for survival and growth to produce lactate36. This 
metabolic reprogramming is dependent on the activation of PI3K signaling, as demonstrated in naive T cells 
and cancer cells37,38. Of interest, it has previously been reported that corticosteroid resistance in T-lineage acute 
lymphoblastic leukemia is associated with the upregulation of glycolysis and activation of PI3K/Akt/mTOR sig-
naling11,12. We observed a switch to glycolysis in Rho-0 cells, as indicated by increased lactate production and 
reduced expression of specific OXPHOS components. Furthermore, we found that inhibition of PI3K reversed 
the ICS unresponsiveness of CXCL8 production in A549 Rho-0 cells. PI3K inhibition itself significantly reduced 
CXCL8 production, and the insensitivity of CXCL8 to ICS in A549 Rho-0 cells could thus be a consequence 
of PI3K activity being insensitive to corticosteroids, resulting in corticosteroid-insensitive CXCL8 production. 
Alternatively, the increased PI3K activity may have resulted in general corticosteroid responsiveness, e.g. by 
mechanisms involving glycogen synthase kinase (GSK)-3β inactivation and post-translational histone deacetylase 
2 (HDAC2) modifications and proteasomal degradation of HDAC2, leading to altered acetylation of the corti-
costeroid receptor and/or histones within the promoter regions of pro-inflammatory genes3,39,40. We previously 
Figure 5. Schematic of proposed processes upon mitochondrial DNA (mtDNA) depletion in lung epithelial 
cells. During homeostasis, ATP is produced by oxidative phosphorylation and there is a balance between active 
and inactive PI3K/GSK-3βsignaling, ensuring limited glycolysis. Upon mitochondrial damage/dysfunction 
induced by mtDNA depletion, increased release of reactive oxygen species (ROS) production results in 
increased activity of redox sensitive kinases such as PI3K and a subsequent increase in production of pro-
inflammatory mediators. Cells can no longer perform normal electron transport for ATP synthesis and rely 
on ATP derived from glycolysis, which is accompanied by impairment/exhaustion of repair responses. This 
glycolytic switch is promoted by the activation of PI3K signaling and subsequent inactivation of GSK-3β and 
HDAC2, resulting in reduced corticosteroid sensitivity of pro-inflammatory responses as well as reduced 
potential of corticosteroids to improve barrier integrity, the latter through mechanisms that need further 
elucidation.
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demonstrated that IL-17 reduces ICS responsiveness of CXCL8 production in airway epithelial cells in a PI3K and 
HDAC2-dependent manner41. Similar mechanisms may be involved corticosteroid unresponsiveness of CXCL8 
upon mtDNA depletion, although further studies will be required to establish this. Cells depleted of functional 
mitochondria were also less sensitive to ICS with respect to effects on the integrity of the epithelial monolayer, 
supporting the notion of general corticosteroid unresponsiveness in these cells. Since ICS fail to efficiently sup-
press inflammation in the majority of COPD patients, it will be of interest to elucidate the precise mechanisms of 
corticosteroid unresponsiveness in mitochondria-depleted epithelial cells in future studies.
In addition to the effects on pro-inflammatory responses and corticosteroid responsiveness, our findings sug-
gest that mitochondrial dysfunction has implications for lung tissue repair in COPD. We observed that mito-
chondrial depletion impairs the ability of the A549 cells to repair upon injury. Although we did not further study 
the mechanisms by which functionally intact mitochondria promote epithelial regeneration, it is conceivable that 
epithelial migration to cover the wounded area requires active energy metabolism. Metabolic reprogramming 
may thus be involved in the impaired epithelial regeneration that is thought to contribute to the pathogenesis 
of the disease. In line with such a role for mitochondrial dysfunction in the pathogenesis of COPD, Mizumura 
and co-workers have shown that cigarette smoke causes mitochondrial dysfunction in a mouse model of COPD, 
while Pink1 deficient mice were protected from mitochondrial dysfunction and airspace enlargement upon cig-
arette smoke exposure9. Of note, lung ageing is also associated with mitochondrial dysfunction, accompanied 
by exhausted repair capacity of stem/progenitor cells and emphysema-like features8,42–44. In contrast to the det-
rimental effect of PI3K/Akt signaling with respect to cytokine production and corticosteroid responsiveness, the 
inhibition of PI3K completely abolished the ability of A549 Rho-0 cells to recover from wounding. These data 
indicate that different mechanisms are responsible for abnormal inflammatory and impaired repair responses 
upon mitochondrial dysfunction and confirm that Rho-0 cells rely on PI3K-dependent activation of glycolysis for 
metabolic activity involved in repair responses (Fig. 5).
Our current findings are limited to the use of a cell line, since the depletion of mtDNA for creating Rho-0 cells 
requires long-term passaging of cells during exposure to a low dose of ethidium bromide. Moreover, A549 cells 
are cancerous and it is worth mentioning that metabolic pathways may be shifted to some extent in carcinoma 
cells at baseline, an effect known as the Warburg effect. Therefore, in future studies, it will be of interest to test the 
effect of mitochondrial inhibitors in non-cancerous primary epithelial cells.
In conclusion, our data indicate that mitochondrial dysfunction leads to increased pro-inflammatory activity, 
inefficient repair and reduced responsiveness to GCs in alveolar epithelium. Our results suggest that novel strat-
egies towards improved mitochondrial function may be promising in COPD. Furthermore, restoration of steroid 
responsiveness, e.g. by means of pharmacological inhibition of the PI3K pathway, may increase the beneficial 
effects of corticosteroids on lung epithelial cells in COPD.
Data availability
The datasets generated during the current study are available from the corresponding author on reasonable 
request.
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